NCT04568460 is a Phase 2 clinical trial of Intervention Group Sessions in HIV, sponsored by Brigham and Women's Hospital.

Who is sponsoring NCT04568460?

NCT04568460 is sponsored by Brigham and Women's Hospital.

What drugs are being tested in NCT04568460?

Interventions in NCT04568460: Intervention Group Sessions.

Is NCT04568460 still recruiting?

NCT04568460 is currently status unknown. Last updated 18 March 2024.

Last reviewed 2024-03-18 · How we verify

NCT04568460

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Standing Tall (Yima Nkqo)

Status unknown Phase 2 Last updated 18 March 2024

What this trial tests

Phase 2 trial testing Intervention Group Sessions in HIV in 100 participants. Status unknown.

Timeline

25 November 2020

Primary endpoint
31 March 2024

31 March 2024

Quick facts

Lead sponsor	Brigham and Women's Hospital
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	25 November 2020
Primary completion	31 March 2024
Estimated completion	31 March 2024
Sites	3 locations across South Africa, United States

Drugs / interventions tested

Intervention Group Sessions

Conditions studied

HIV — all drugs for HIV →

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 24, any sex, with HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators propose the Standing Tall study, a prospective randomised study of strategy to optimize community-based ART initiation in South Africa. Investigators will work closely with community members to integrate community-based ART. One hundred participants will be enrolled and followed for a total of up to 6 months. Those in the intervention arm will be provided with the ST intervention which includes a behavioral component and access to ART. The intervention will be linked to a clinic through a "Nurse Initiated Management of ART."

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Development of "Yima Nkqo," a community-based, peer group intervention to support treatment initiation for young adults with HIV in South Africa.
Nardell MF, Sindelo S, Rousseau E, Siko N, et al · · 2023 · cited 5× · PMID 37319250 · DOI 10.1371/journal.pone.0280895
A Moderated Mediation Model of HIV-Related Anticipated Stigma and Social Capital on the Relationship Between Diagnosis During the COVID-19 Pandemic and Potentially Problematic Substance Use Among Young South Africans.
Bondarchuk CP, Lemon T, Medina-Marino A, Rousseau E, et al · · 2025 · PMID 41249762 · DOI 10.1007/s12529-025-10415-5
Urine tenofovir adherence testing: Perspectives of recently diagnosed South African adolescents and young adults with HIV accessing care via mobile HIV clinics.
Montaño MA, Sindelo S, Fata A, Rousseau E, et al · · 2025 · PMID 39888950 · DOI 10.1371/journal.pone.0318308

Verify or expand the search:

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04568460 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
Last refreshed: 18 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04568460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing